This medication category includes weekly injectables and daily oral pills: Semaglutide (Wegovy , Ozempic ) Tirzepatide (Zepbound , Mounjaro ) Orforglipron (Foundayo ) The FDA approves these specific brands for different uses: Wegovy , Zepbound , and Foundayo for weight management, and Ozempic and Mounjaro for type 2 diabetes
Tirzepatide presents a groundbreaking option for individuals with type 2 diabetes, offering the dual benefits of blood sugar control and weight loss
The insulin levels in people with type 2 diabetes are known to be lower than those in people without diabetes, and the GLP-1 drugs help balance them
For once-daily oral semaglutide, skip the missed dose and resume the following daydo not double up
For a 200-pound person, it means 24 to 30 pounds
You're essentially choosing between a systemic metabolic optimizer and a targeted neurological appetite controller